Tarsus Pharmaceuticals Inc. (TARS) Live Share Price, Invest From India

Tarsus Pharmaceuticals Inc. Stock Performance

as on July 25, 2026 at 2:15 pm IST

Day's Low
Day's High
$57.54
Day's Price Range
$59.05
$58.66
1.91%
Downside
0.66%
Upside
52 Week's Low
52 Week's High
$38.51
52-Week Price Range
$85.25
$58.66
34.35%
Downside
45.33%
Upside

Tarsus Pharmaceuticals Inc. share price movements today

Previous Close: $58.58
Open: $59.05
Volume: 288.7K
Day's Low - High: $57.54 - $59.05
52 Week Low - High: $38.51 - $85.25

Tarsus Pharmaceuticals Inc. Historical Returns

1 Month Return: -8.83 %
3 Month Return: -4.54 %
1 Year Return: + 41.35 %
3 Year Return: + 225.26 %
5 Year Return: + 126.4 %

Tarsus Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Tarsus Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6B

EPS (TTM)

-2.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-49.0M

Revenue (TTM)

535.1M

Profit Margin

-9.02%

Return On Equity TTM

-13.96%

Tarsus Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tarsus Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tarsus Pharmaceuticals Inc.	BUY	$2.6B	126.4%	NA	-9.02%	NA
Revolution Medicines Inc.	BUY	$40.1B	553.87%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.1B	138.08%	28.01	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$68.3B	11.88%	15.9	29.65%	0.5499999999999999%

Stock Returns calculator for Tarsus Pharmaceuticals Inc. Stock including INR - Dollar returns

The Tarsus Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tarsus Pharmaceuticals Inc. investment value today

Current value as on today

₹1,57,995

Returns

₹57,995

(+57.99%)

Returns from Tarsus Pharmaceuticals Inc. Stock

₹41,349 (+41.35%)

Dollar Impact

₹16,645 (+16.65%)

Analyst Recommendation on Tarsus Pharmaceuticals Inc. Stock

Based on 15 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Tarsus Pharmaceuticals Inc.. Average target price of $94.44

Tarsus Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Tarsus Pharmaceuticals Inc..

What analysts predicted

37.89%UPSIDE

Target Price

$94.44

Current Price

$58.66

Analyzed by

15 Analysts

Target

$94.44

Tarsus Pharmaceuticals Inc. target price $94.44, a slight upside of 37.89% compared to current price of $58.66. According to 15 analysts rating.

Indian Investors' Interest in Tarsus Pharmaceuticals Inc. Stock

Search interest for Tarsus Pharmaceuticals Inc. Stock has increased by 361% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 25, 2026 to July 25, 2026

Change:361% versus previous 30 day period

Tarsus Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	13	27	40	48	66	78	102	118	151	162
Gross Profit	11	25	37	44	61	73	96	94	140	152
Operating Income	-44	-37	-33	-25	-24	-26	-22	-14	-7	-6
EBITDA	-40	-34	-30	-20	-20	-22	-17	-12	-3	-6
Interest Expense	0	0	2	2	2	2	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-41	-35	-33	-23	-23	-25	-20	-12	-6	-9
Income Tax Expense	30	0	-	-	-	-	-	-	2	-2
Net Income	-41	-35	-33	-23	-23	-25	-20	-12	-8	-6
Net Profit Margin	-320.45%	-129.39%	-81.57%	-48.67%	-34.80%	-32.07%	-19.81%	-10.60%	-5.52%	-4.30%

Tarsus Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	33	57	25	17	182	451
Gross Profit	0	0	0	54	24	15	170	420
Operating Income	-1	-4	-26	-12	-62	-143	-120	-70
EBITDA	-1	-4	-26	-13	-59	-131	-106	-53
Interest Expense	-	0	0	2	2	3	7	8
Depreciation	0	0	0	0	0	0	1	1
Income Before Tax	-1	-4	-26	-13	-62	-135	-115	-64
Income Tax Expense	0	0	0	0	0	0	-	2
Net Income	-1	-4	-26	-13	-62	-135	-115	-66
Net Profit Margin	0.00%	0.00%	-80.20%	-24.25%	-240.51%	-778.89%	-63.16%	-14.72%

Tarsus Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-35	-33	-23	-23	-25	-20	-12	-8	-6
Operating Cash Flow	-37	-14	-8	-22	-20	-29	18	19	-24
Investing Cash Flow	-102	-40	3	-59	-34	-51	-4	49	-58
Financing Cash Flow	108	42	0	2	136	1	2	2	1
Change in Cash	-31	-12	-4	-78	80	-79	16	70	-82

Tarsus Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-26	-13	-62	-135	-115	-66
Operating Cash Flow	-3	-21	3	-49	-117	-83	-12
Investing Cash Flow	0	0	0	-144	140	-199	-42
Financing Cash Flow	59	131	0	93	130	154	143
Change in Cash	55	110	3	-99	153	-127	88

Global Institutional Holdings in Tarsus Pharmaceuticals Inc.

Funds	Holdings
Amvescap Plc.	1.74%
BlackRock Inc	8.35%
Delaware Management Holdings Inc	1.36%
RTW INVESTMENTS, LLC	7.86%
HHG PLC	5.27%

See all

Insights on Tarsus Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 years, TARS stock has moved up by 225.3%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.2% return, outperforming this stock by 357.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 634.9% return, outperforming this stock by 409.6%

About Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Organisation	Tarsus Pharmaceuticals Inc.
Headquarters	17700 Laguna Canyon Road, Irvine, CA, United States, 92618
Industry	Biotechnology
CEO	Dr. Bobak R. Azamian M.D.
E-voting on shares	Click here to vote

Key Management of Tarsus Pharmaceuticals Inc.

Name	Title
Dr. Bobak R. Azamian M.D.	Co-Founder, President, CEO & Chairman
Dr. Seshadri Neervannan Ph.D.	Chief Operating Officer
Dr. Bryan Wahl J.D., M.D.	General Counsel & Corporate Secretary

FAQs

What is Tarsus Pharmaceuticals Inc. share price today?

Tarsus Pharmaceuticals Inc. share price today is $58.66 as on July 25, 2026 at 8:45 am IST at the close of the market. Tarsus Pharmaceuticals Inc. share today touched a day high of $59.05 and a low of $57.54.

What is the 52 week high and 52 week low for Tarsus Pharmaceuticals Inc. share?

Tarsus Pharmaceuticals Inc. share touched a 52 week high of $85.25 on December 9, 2025 and a 52 week low of $38.51 on August 1, 2025. Tarsus Pharmaceuticals Inc. stock price today i.e. July 25, 2026 at 8:45 am IST is closed at $58.66,which is 31.19% down from its 52 week high and 52.32% up from its 52 week low.

What is Tarsus Pharmaceuticals Inc.'s market capitalisation today?

Tarsus Pharmaceuticals Inc. market capitalisation is $0.00T as on July 25, 2026 at 8:45 am IST.

How to invest in Tarsus Pharmaceuticals Inc. Stock (TARS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tarsus Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tarsus Pharmaceuticals Inc. Shares that will get you 0.0256 shares as per Tarsus Pharmaceuticals Inc. share price of $58.66 per share as on July 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Tarsus Pharmaceuticals Inc. Stock (TARS) from India?

Indian investors can start investing in Tarsus Pharmaceuticals Inc. (TARS) shares with as little as ₹96.552 or $1 (as of July 25, 2026 at 2:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.52 in Tarsus Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on July 25, 2026 at 2:39 pm IST). Based on Tarsus Pharmaceuticals Inc. share’s latest price of $58.66 as on July 25, 2026 at 8:45 am IST, you will get 0.1705 shares of Tarsus Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Tarsus Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Tarsus Pharmaceuticals Inc. stock has given 126.4% share price returns and 29.46% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?